CRMAX
Price
$10.04
Change
+$0.04 (+0.40%)
Updated
Jul 16 closing price
Net Assets
129.09M
FSMDX
Price
$35.59
Change
+$0.18 (+0.51%)
Updated
Jul 16 closing price
Net Assets
42.38B
Interact to see
Advertisement

CRMAX vs FSMDX

Header iconCRMAX vs FSMDX Comparison
Open Charts CRMAX vs FSMDXBanner chart's image
CRM Small/Mid Cap Value I
Price$10.04
Change+$0.04 (+0.40%)
VolumeN/A
Net Assets129.09M
Fidelity Mid Cap Index
Price$35.59
Change+$0.18 (+0.51%)
VolumeN/A
Net Assets42.38B
CRMAX vs FSMDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CRMAX vs. FSMDX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a Hold and FSMDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 42.4B vs. CRMAX (129M). FSMDX pays higher dividends than CRMAX: FSMDX (1.31) vs CRMAX (0.30). CRMAX was incepted earlier than FSMDX: CRMAX (21 years) vs FSMDX (14 years). CRMAX (1.21) is less costly to investors than FSMDX (0.03). CRMAX is a more actively managed with annual turnover of: 72.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than CRMAX: FSMDX (0) vs CRMAX (2500). FSMDX annual gain was more profitable for investors over the last year : 8.58 vs. CRMAX (-14.88). FSMDX return over 5 years is better than : 70.17 vs. CRMAX (1.54).
CRMAXFSMDXCRMAX / FSMDX
Total Expense Ratio1.210.034,840%
Annual Report Gross Expense Ratio1.210.034,840%
Fund Existence21 years14 years-
Gain YTD-7.6645.111-150%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets129M42.4B0%
Annual Yield % from dividends0.301.3123%
Returns for 1 year-14.888.58-173%
Returns for 3 years3.1645.927%
Returns for 5 years1.5470.172%
Returns for 10 years-31.41117.56-27%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GROV1.510.08
+5.59%
Grove Collaborative Holdings
ANIK11.190.19
+1.73%
Anika Therapeutics
COMP6.580.10
+1.54%
Compass
BWA35.170.18
+0.51%
BorgWarner
ABLLL24.75-0.04
-0.16%
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028